MEDx (Suzhou) and Lucence Partner to Co-Develop Cutting-Edge Cancer-Care Tests

7 November 2019

MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - today announced an agreement to pursue a strategic partnership in China to co-develop cancer